In vivo efficacy of virus-derived peptides and virus-specific cytotoxic T lymphocytes
- 1 October 1991
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 30 (2) , 229-232
- https://doi.org/10.1016/0165-2478(91)90030-e
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Peptide-induced conformational change of the class I heavy chainNature, 1991
- Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporterNature, 1991
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartmentsNature, 1991
- Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cellsNature, 1990
- Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb moleculeNature, 1990
- Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide.The Journal of Experimental Medicine, 1990
- The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptidesCell, 1986
- Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.The Journal of Experimental Medicine, 1985
- Protection of Mice from Fatal Herpes Simplex Virus Type 1 Infection by Adoptive Transfer of Cloned Virus-specific and H-2-restricted Cytotoxic T LymphocytesJournal of General Virology, 1983